MASTER PROMPT: THYROID SWELLING (MS GENERAL SURGERY LONG CASE) Act as a Professor of General Surgery, University Examiner, Endocrine Surgeon, and Consultant Thyroid Surgeon with over 40 years of teaching experience. Teach Thyroid Swelling exactly as expected in MS General Surgery (India), DNB, MCh entrance, and university practical/clinical examinations. Base the discussion on the latest editions of: * Bailey & Love’s Short Practice of Surgery * Sabiston Textbook of Surgery * Schwartz’s Principles of Surgery * S. Das Manual on Clinical Surgery * SRB Manual of Surgery * Bedside Clinics in Surgery (Makhan Lal Saha) * Latest American Thyroid Association (ATA), European Thyroid Association (ETA), British Thyroid Association (BTA), ASI, and NCCN guidelines. Learning Objectives The output should enable a postgraduate resident to: * Present a thyroid swelling confidently in a university examination. * Perform a complete bedside examination. * Differentiate benign from malignant thyroid swellings. * Interpret thyroid investigations. * Plan medical and surgical management. * Answer examiner cross-questions confidently. ⸻ Structure the discussion as follows: 1. Clinical Scenario Generate a realistic university long-case patient including: * Age, sex, occupation * Chief complaints * Duration * History of neck swelling * Pressure symptoms * Hyperthyroid symptoms * Hypothyroid symptoms * Voice changes * Radiation exposure * Family history (MEN syndromes, thyroid cancer) * Examination findings * Working diagnosis ⸻ 2. Relevant Surgical Anatomy Discuss: * Embryology of the thyroid gland * Surgical anatomy of the thyroid gland * Lobes and isthmus * Capsule (true and false) * Blood supply * Venous drainage * Lymphatic drainage * Nerve supply * Recurrent laryngeal nerve (RLN) * External branch of superior laryngeal nerve (EBSLN) * Parathyroid glands * Berry’s ligament * Tubercle of Zuckerkandl * Pyramidal lobe * Thyrothymic ligament * Applied surgical anatomy Include labeled anatomical diagrams from standard textbooks. ⸻ 3. Classification Discuss with flowcharts: * Diffuse goitre * Multinodular goitre * Solitary thyroid nodule * Toxic goitre * Graves disease * Toxic multinodular goitre * Toxic adenoma * Thyroiditis * Benign neoplasms * Malignant neoplasms * Retrosternal goitre * WHO and Bethesda classifications where applicable ⸻ 4. Complete History Taking Cover: * Neck swelling * Duration * Rate of growth * Pain * Dysphagia * Dyspnea * Stridor * Hoarseness * Hyperthyroidism symptoms * Hypothyroidism symptoms * Radiation exposure * Family history * MEN syndrome history * Previous thyroid surgery * Drug history (amiodarone, lithium) * Pregnancy history (when relevant) Include examiner cross-questions after each section. ⸻ 5. Complete Clinical Examination Describe: General Examination * Build and nutrition * Pulse * Blood pressure * Tremors * Warm hands * Eye signs * Pretibial myxedema * Acropachy Local Examination * Inspection * Palpation * Swallowing test * Tongue protrusion test * Consistency * Nodularity * Surface * Borders * Tenderness * Lower border assessment * Retrosternal extension * Tracheal deviation * Cervical lymph nodes * Auscultation for bruit * Pemberton sign * Crile’s method * Lahey’s method * Kocher’s test Explain the significance of every finding. Include examination diagrams and clinical photographs wherever useful. ⸻ 6. Special Clinical Tests Discuss: * Swallowing test * Tongue protrusion test * Pemberton sign * Crile’s method * Lahey’s method * Tracheal assessment * Vocal cord assessment * Airway evaluation For each test include: * Indication * Technique * Positive findings * Interpretation * Limitations * Common viva questions ⸻ 7. Differential Diagnosis Compare: * Thyroid swelling * Thyroglossal cyst * Dermoid cyst * Branchial cyst * Lymphadenopathy * Lipoma * Sebaceous cyst * Laryngocele * Carotid body tumor * Salivary gland swellings Use detailed comparison tables. ⸻ 8. Case Presentation Provide a polished 5-minute university-style long-case presentation. ⸻ 9. Investigations Discuss: * TSH * Free T3/T4 * Thyroid antibodies * Ultrasound (TI-RADS) * FNAC (Bethesda classification) * Thyroid scan * CT neck/chest * MRI * Flexible laryngoscopy * Serum calcitonin * Serum thyroglobulin * RET mutation testing (where indicated) Include investigation algorithms and representative images. ⸻ 10. Management Provide evidence-based algorithms covering: Medical * Observation * Levothyroxine * Antithyroid drugs * Beta blockers * Radioiodine therapy Surgical * Hemithyroidectomy * Total thyroidectomy * Near-total thyroidectomy * Completion thyroidectomy * Central compartment neck dissection * Lateral neck dissection Discuss indications, contraindications, and guideline recommendations. Compare Bailey & Love, Sabiston, and ATA guidelines. ⸻ 11. Operative Discussion For each thyroid operation include: * Indications * Contraindications * Patient positioning * Kocher incision * Operative anatomy * Step-by-step operative technique * Identification and preservation of RLN * Identification and preservation of parathyroid glands * Hemostasis * Specimen removal * Closure * Instruments * Pitfalls * Complications * Prevention Include operative diagrams and standard textbook illustrations. ⸻ 12. Complications Discuss: * Hemorrhage * Neck hematoma * Airway obstruction * RLN injury * EBSLN injury * Hypocalcemia * Hypoparathyroidism * Thyroid storm * Wound infection * Seroma * Recurrence Provide management flowcharts. ⸻ 13. Complete Viva Section Include: * 100+ examiner questions with model answers * Cross-question chains * Specimen viva * Histopathology viva * Ultrasound/FNAC viva * Instrument viva * Operative viva * Emergency scenarios * Ward-round discussion ⸻ 14. Image-Based Discussion Include authentic textbook or guideline images of: * Thyroid anatomy * Embryology * Clinical photographs * Eye signs of Graves disease * Ultrasound (TI-RADS) * Thyroid scintigraphy * FNAC cytology (Bethesda) * Histopathology * Thyroidectomy steps * RLN anatomy * Parathyroid preservation * Surgical instruments Do not use AI-generated images. Prefer authentic textbook and guideline figures with proper attribution. ⸻ 15. Flowcharts Provide flowcharts for: * Approach to thyroid swelling * Solitary thyroid nodule * Diffuse goitre * Hyperthyroidism * Thyroid malignancy * Investigation pathway * Bethesda-based management * Operative decision-making * Postoperative hypocalcemia management * Follow-up ⸻ 16. Mind Maps Create concise text-based mind maps for rapid revision. ⸻ 17. High-Yield MS/DNB Pearls Highlight: * Frequently asked long-case questions * Examiner’s favorite cross-questions * Common candidate mistakes * OSCE stations * One-liners * Mnemonics * Red flags * Clinical decision-making pearls ⸻ 18. Final Revision End with: * One-page rapid revision sheet * Top 50 viva questions * Top 20 one-liners * Top 10 examiner traps * Top 10 thyroid examination pearls * Top 10 operative pearls * Key flowchart summary * Last-minute memory mnemonics Presentation Requirements * Use clear headings, bullet points, comparison tables, algorithms, and flowcharts throughout. * Focus on bedside examination, endocrine surgical anatomy, clinical reasoning, and viva performance. * Compare recommendations from Bailey & Love, Sabiston, and current ATA/ETA/BTA guidelines wherever they differ. * Include authentic clinical photographs, ultrasound images, cytology, histopathology, operative illustrations, and anatomical diagrams whenever they enhance learning.

Reading File

Now let me run parallel queries to gather the most comprehensive thyroid content from the medical library and latest guidelines simultaneously.

Finding Sources

Searching PubMed

"thyroid nodule" AND management

Searching the Web

ATA 2015 thyroid nodule guidelines Bethesda system TIRADS 2023 update

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have rich textbook content from Schwartz's, Robbins, Scott-Brown's, and the latest ETA 2023 guidelines. Let me now fetch the key operative anatomy and lymph node images, and then compile the complete master document.

Loading Image

Reading File

Now I have everything needed to compile the comprehensive master document. I'll now deliver the full, structured, examiner-grade MS General Surgery Thyroid Long Case.

THYROID SWELLING - MS GENERAL SURGERY LONG CASE

Complete University Examination Guide

Professor of General Surgery | University Examiner | Endocrine Surgeon Based on: Schwartz's (11e), Bailey & Love (27e), Sabiston (21e), S.Das, SRB, Saha | ATA 2015, ETA 2023, BTA, NCCN Guidelines

SECTION 1: CLINICAL SCENARIO

Model Long Case - University Examination

Patient: Mrs. Savitha Reddy, 38 years, female, school teacher, from Hyderabad.

Chief Complaints:

Swelling in the front of the neck - 4 years
Rapid increase in size - 3 months
Discomfort on swallowing - 2 months
Change in voice (hoarseness) - 3 weeks

History of Presenting Illness:

The patient noticed a small swelling on the right side of the neck 4 years ago, the size of a "gooseberry," which she initially ignored. The swelling gradually increased over the years. Three months ago, she noticed a sudden, rapid increase in size of the swelling associated with mild aching pain. She also noticed a feeling of fullness and discomfort while swallowing solids for the past 2 months. For the past 3 weeks, she has noted a change in voice - mild hoarseness.

Pressure Symptoms:

Dysphagia (solids > liquids) - present
Dyspnea on exertion - mild, present
No stridor at rest
Hoarseness of voice - present (3 weeks, SIGNIFICANT - suggests RLN involvement)

Hyperthyroid Symptoms: None - no palpitations, no excessive sweating, no heat intolerance, no weight loss, no tremors.

Hypothyroid Symptoms: None - no weight gain, no cold intolerance, no constipation, no lethargy.

Risk Factors:

No history of neck irradiation
No family history of thyroid cancer, MEN syndrome, or RET mutations
No previous thyroid surgery
No amiodarone or lithium use
Menarche: 13 years, regular cycles, 2 children, no pregnancy-related thyroid history

Working Diagnosis: Right-sided solitary thyroid nodule (likely malignant - given rapid growth + hoarseness) - Rule out Papillary Thyroid Carcinoma.

SECTION 2: SURGICAL ANATOMY

2.1 Embryology

Thyroid embryology - median thyroid diverticulum descending from pharyngeal pouches (Schwartz's 11e)

Figure: Thyroid embryology - early development of the median thyroid anlage as a pharyngeal pouch. (Schwartz's Principles of Surgery, 11e, Fig. 38-1)

Key Embryological Facts:

Thyroid is the first endocrine gland to develop (3rd-4th week of gestation)
Arises from the foramen caecum at the junction of the anterior 2/3 and posterior 1/3 of the tongue - the median thyroid anlage
Descends along the thyroglossal duct (which normally obliterates by 8th week) through the tongue base, anterior to the hyoid bone, and infrahyoid strap muscles, to its final position in the neck
The parafollicular C cells (calcitonin-secreting) arise from the 4th pharyngeal pouch (ultimo-branchial body)
Superior parathyroids arise from the 4th pharyngeal pouch
Inferior parathyroids arise from the 3rd pharyngeal pouch (same pouch as thymus)

Surgical Significance of Embryology:

Anomaly	Mechanism	Clinical Significance
Thyroglossal duct cyst	Failure of obliteration of thyroglossal duct	Moves upward on tongue protrusion (Sistrunk operation)
Lingual thyroid	Failure of descent	May be only thyroid tissue - do thyroid scan before surgery
Pyramidal lobe	Persistence of lower end of thyroglossal duct	Present in 50%; hypertrophies in Graves disease
Accessory thyroid tissue	Along any point of descent pathway	Can be missed on thyroidectomy
Lateral aberrant thyroid	None	Does NOT exist - always means lymph node metastasis from PTC

2.2 Surgical Anatomy of the Thyroid Gland

Gross Anatomy:

Weight: 25-35 g (normal adult)
Shape: H-shaped or butterfly-shaped
Two lateral lobes connected by the isthmus overlying tracheal rings 2-4
Dimensions of each lobe: 5 cm (height) x 3 cm (width) x 2 cm (depth)
Pyramidal lobe present in ~50% of individuals, ascending from the isthmus (or left lobe) toward the hyoid - hypertrophies in Graves disease and Hashimoto thyroiditis

Capsule:

True capsule: Derived from the thyroid gland itself; sends fibrous septa into the gland forming pseudolobules
False capsule (surgical capsule): Derived from the pretracheal layer of deep cervical fascia; between true and false capsule lie the main blood vessels, nerves, and parathyroid glands
The false capsule is condensed posteriorly to form Berry's ligament (suspensory ligament) - attaching the thyroid to tracheal rings 2-4

Berry's Ligament - Surgical Importance:

Fixes the thyroid to the trachea
The RLN passes deep (posterior) to Berry's ligament or through its substance in 25% of cases
Dividing Berry's ligament is a step in total thyroidectomy - DANGER zone for RLN
The Tubercle of Zuckerkandl (posterolateral extension of the thyroid, present in 60-80%) is found at the medial aspect of Berry's ligament and serves as a landmark for the RLN

2.3 Blood Supply

Arterial Supply:

Artery	Origin	Supply
Superior thyroid artery (STA)	1st branch of external carotid artery	Upper poles of thyroid
Inferior thyroid artery (ITA)	Thyrocervical trunk (subclavian)	Lower poles, posterior surface, parathyroids
Thyroidea ima artery	Directly from arch of aorta or brachiocephalic	Isthmus (present in 1-4%)

Venous Drainage (Inferior, Middle, Superior):

Vein	Drains into
Superior thyroid vein	Internal jugular vein (or common facial vein)
Middle thyroid vein	Internal jugular vein (LIGATED FIRST in thyroidectomy - "vein of safety")
Inferior thyroid vein	Left brachiocephalic vein

Examiner Pearl: The middle thyroid vein is the first structure divided in thyroidectomy - it provides mobilization of the lobe and is a key safety step.

2.4 Nerve Supply - THE MOST IMPORTANT SURGICAL ANATOMY

Recurrent Laryngeal Nerve (RLN)

Course:

Branch of the vagus nerve (CN X)
Right RLN: Loops around the right subclavian artery; runs in the tracheoesophageal groove, shorter and more oblique course
Left RLN: Loops around the arch of the aorta (ligamentum arteriosum); longer course, more vertical in the tracheoesophageal groove

Relations to Inferior Thyroid Artery (ITA): The relationship is variable and surgically treacherous:

RLN passes anterior to ITA: 37%
RLN passes posterior to ITA: 42%
RLN passes between branches of ITA: 20%

> Rule: Never ligate the ITA close to the thyroid - always ligate the individual branches close to the gland to avoid RLN injury.

Berry's Ligament and RLN:

RLN passes through Berry's ligament in 25% of cases
The Tubercle of Zuckerkandl, when present, lies lateral to where the RLN enters the larynx - a useful surgical landmark
RLN enters the larynx posterior to the cricothyroid joint at the inferior cornu of the thyroid cartilage

Non-recurrent Laryngeal Nerve (NRLN):

Present on the right side in 0.5-1% of cases
Associated with right-sided non-recurrent subclavian artery (arteria lusoria)
Runs directly from vagus to larynx without looping
Can be mistaken for a blood vessel and divided - catastrophic bilateral cord palsy
Use preoperative CT to look for retroesophageal right subclavian artery when NRLN suspected

RLN Injury - Consequences:

Injury Type	Result
Unilateral complete RLN injury	Hoarseness (cord in paramedian/adducted position)
Bilateral complete RLN injury	Aphonia + Respiratory distress (emergency)
Unilateral partial injury (anterior branch)	Hoarseness (abductor spared)
Bilateral anterior branch injury	Stridor, respiratory distress (adductors intact, abductors injured)

External Branch of Superior Laryngeal Nerve (EBSLN) - "High Note Nerve"

Branch of superior laryngeal nerve (branch of vagus)
Runs with the superior thyroid artery before dividing at variable levels
Supplies the cricothyroid muscle (tensor of vocal cord - voice pitch, projection)
Cernea Classification of EBSLN (surgical relevance):
- Type 1: Crosses STA >1 cm above upper pole (safe zone) - 20%
- Type 2a: Crosses STA within 1 cm of upper pole - 12%
- Type 2b: Crosses STA below upper pole (at or below the plane of the upper pole) - most dangerous - 68%
Injury results in: Loss of vocal projection, cannot sing high notes, voice fatigues quickly - the "Amelita Galli-Curci" injury (famous opera singer)
Prevention: Ligate the superior thyroid vessels individually, close to the upper pole

2.5 Parathyroid Glands - Preservation During Thyroidectomy

Number and Location:

Usually 4 glands (range 2-6)
Weight: 30-40 mg each
Color: Tan/yellow-brown (vs. thyroid which is reddish-brown; vs. fat which is yellow)

Gland	Embryological Origin	Typical Location
Superior parathyroid (x2)	4th pharyngeal pouch	Posterior to thyroid, at cricothyroid junction, level of inferior cornu of thyroid cartilage - CONSTANT position
Inferior parathyroid (x2)	3rd pharyngeal pouch	MORE VARIABLE - posterior to lower pole, anterior to RLN, may be intrathymic

Blood Supply:

Primarily from the inferior thyroid artery (both superior and inferior parathyroids in 80%)
Superior parathyroids may receive supply from superior thyroid artery (25%)
Rule: Preserve the inferior thyroid artery at its point of entry into the thyroid (not as a main trunk) - preserves parathyroid blood supply

Identification During Surgery:

Gentle mobilization maintaining fat pad
Do not strip the capsule of the gland
Positive parathyroid test: cut corner of suspected gland - if frozen section confirms parathyroid tissue, autotransplant into sternocleidomastoid or brachioradialis
Devascularized parathyroid = autotransplant (1 mm fragments into muscular pockets)

2.6 Lymphatic Drainage

Cervical lymph node levels I-VII (Schwartz's 11e)

Figure: Cervical lymph node levels I-VII. Central neck = Level VI. Lateral neck = Levels II-V. Level VII = superior mediastinum. (Schwartz's Principles of Surgery, 11e, Fig. 38-6)

Lymphatic Drainage Pattern:

Direction	Nodes Involved
Primarily (central compartment)	Prelaryngeal (Delphian node), pretracheal, paratracheal nodes - Level VI
Lateral	Internal jugular chain (Levels II, III, IV)
Superior	Subdigastric nodes
Inferior	Level VI → Level VII (superior mediastinal)
Skip metastasis	Directly to lateral nodes (Level III) without central - seen in PTC

Delphian Node:

Prelaryngeal lymph node
When enlarged, indicates thyroid malignancy (especially papillary/medullary)
Named "Delphian" as its biopsy "foretells" malignancy - useful intraoperative marker

SECTION 3: CLASSIFICATION

3.1 Master Classification Flowchart

THYROID SWELLING
├── DIFFUSE ENLARGEMENT (Goitre)
│   ├── Non-toxic (Simple/Endemic)
│   │   ├── Diffuse (Simple goitre)
│   │   └── Multinodular goitre (MNG)
│   ├── Toxic
│   │   ├── Graves Disease (Diffuse toxic goitre)
│   │   ├── Toxic Multinodular Goitre (Plummer disease)
│   │   └── Toxic Adenoma (Plummer's solitary toxic nodule)
│   └── Thyroiditis
│       ├── Hashimoto's (autoimmune)
│       ├── Subacute (De Quervain's)
│       ├── Riedel's (fibrous)
│       ├── Postpartum thyroiditis
│       └── Drug-induced
│
├── SOLITARY THYROID NODULE (STN)
│   ├── Benign (95%)
│   │   ├── Follicular adenoma (most common)
│   │   ├── Colloid cyst
│   │   ├── Thyroid cyst (simple)
│   │   ├── Hashimoto's nodule
│   │   └── Dominant nodule in MNG
│   └── Malignant (5%)
│       ├── Well-differentiated
│       │   ├── Papillary carcinoma (80-85%)
│       │   └── Follicular carcinoma (10-15%)
│       ├── Poorly differentiated
│       │   ├── Hurthle cell (5%)
│       │   └── Poorly differentiated NOS
│       ├── Undifferentiated (Anaplastic) (1-2%)
│       ├── Medullary carcinoma (3-5%)
│       └── Others: lymphoma, metastatic
│
└── RETROSTERNAL GOITRE
    ├── Primary (1-2%) - arises in mediastinum
    └── Secondary (majority) - descends from neck goitre

3.2 WHO Classification of Goitre (Field Grading)

Grade	Description
Grade 0	No goitre visible or palpable
Grade 1	Goitre palpable but not visible when neck in normal position; moves upward on swallowing
Grade 2	Goitre visible when neck is in normal position; consistent with enlargement when neck is palpated

Note: Used in epidemiological surveys for iodine deficiency assessment.

3.3 Thyroiditis Classification

Type	Cause	Thyroid Function	Key Feature
Hashimoto's (chronic autoimmune)	Anti-TPO, anti-Tg antibodies	Hypothyroid (usually)	Most common thyroiditis; increased lymphoma risk
Subacute granulomatous (De Quervain's)	Post-viral (Coxsackievirus, mumps)	Hyper → Hypo → Normal	Painful; raised ESR; self-limiting
Riedel's fibrosing thyroiditis	Unknown (IgG4 disease)	Hypo	"Woody" hard thyroid; compresses trachea/esophagus
Postpartum thyroiditis	Autoimmune	Hyper → Hypo	Within 1 year postpartum
Drug-induced	Amiodarone, lithium, interferon	Variable	History is key

3.4 TNM Staging of Thyroid Cancer (AJCC 8th Edition, 2017)

Stage	Criteria
Papillary/Follicular (age <55 years)
Stage I	Any T, Any N, M0
Stage II	Any T, Any N, M1
Papillary/Follicular (age ≥55 years)
Stage I	T1-T2, N0/NX, M0
Stage II	T1-T2, N1, M0 OR T3a/T3b, Any N, M0
Stage III	T4a, Any N, M0
Stage IVA	T4b, Any N, M0
Stage IVB	Any T, Any N, M1
Medullary/Anaplastic	All anaplastic = Stage IV

Examiner Pearl: The AJCC 8th edition (2017) moved the age cutoff from 45 to 55 years for differentiated thyroid cancer staging - a major change from the 7th edition. This results in many patients being downstaged.

SECTION 4: COMPLETE HISTORY TAKING

4.1 Template: History of Thyroid Swelling

A. SWELLING

Duration: When did the swelling first appear? ("4 years ago")
Rate of growth:
- Slow - benign (adenoma, colloid nodule)
- Rapid growth over weeks/months - MALIGNANCY or hemorrhage into cyst
- Rapid growth + pain = hemorrhage into cyst or De Quervain's thyroiditis
- Rapid growth without pain = ANAPLASTIC CARCINOMA (emergency)
Site of onset: Midline or lateral; right lobe more common
Change in size: Does it fluctuate? (cyst may fluctuate; goitre may enlarge with menstruation/pregnancy)
Associated pain: Sudden onset of pain = hemorrhage into cyst; chronic dull ache = malignancy

B. PRESSURE SYMPTOMS

Symptom	Significance
Dysphagia	Esophageal compression (large goitre)
Dyspnea	Tracheal compression
Stridor	Severe tracheal compression - EMERGENCY
Hoarseness	RLN involvement - MALIGNANCY until proven otherwise
Venous engorgement	SVC compression (retrosternal) - positive Pemberton sign

C. HYPERTHYROID SYMPTOMS (TOPS)

Tremors (fine tremor of hands)
Ophthalmopathy (eye prominence, double vision)
Palpitations (tachycardia, AF)
Sweating, heat intolerance, weight loss despite normal appetite, anxiety, diarrhea, oligomenorrhea, insomnia

D. HYPOTHYROID SYMPTOMS (SLOW)

Skin changes (dry, rough, myxedema)
Lethargy, cold intolerance
Obesity/weight gain, constipation
Weight gain, bradycardia, deep husky voice, menorrhagia, depression

E. RISK FACTORS FOR MALIGNANCY (HRAFTS - High-Risk Features)

Feature	Risk
History of childhood head/neck irradiation	40x increased risk PTC
Rapid growth + hard nodule	Malignancy
Age extremes (<20 or >60 years)	Higher malignancy risk in males >60
Family history (PTC, MTC, MEN2, FAP, Cowden, PTEN, DICER1)	Genetic syndromes
Texture: hard, fixed, irregular	Malignancy
Sex: male with solitary nodule	Higher risk than female
Hoarseness, dysphagia (pressure symptoms)	Advanced malignancy

F. FAMILY HISTORY

Syndrome	Associated Thyroid Cancer
MEN 2A (RET mutation)	Medullary thyroid carcinoma + pheo + hyperPTH
MEN 2B (RET mutation)	MTC + pheo + marfanoid habitus + mucosal neuromas
Familial MTC (FMTC)	Isolated MTC
FAP/Gardner syndrome	Papillary thyroid carcinoma
Cowden syndrome (PTEN mutation)	Follicular adenoma/carcinoma
DICER1 syndrome	Differentiated thyroid carcinoma
Werner syndrome	Follicular carcinoma

G. DRUG HISTORY

Drug	Effect
Amiodarone (iodine-rich)	Hypo or hyperthyroidism
Lithium	Hypothyroidism, goitre
Interferon-alpha	Thyroiditis, hypothyroid
Checkpoint inhibitors	Thyroiditis
Carbimazole/Propylthiouracil	Prescribed for hyperthyroidism

Examiner Cross-Questions - History Section

Q: What is the single most important symptom suggesting malignancy in a thyroid swelling? A: Hoarseness of voice - indicates RLN involvement, suggesting malignant invasion. Must be assessed preoperatively by flexible laryngoscopy.

Q: A patient with thyroid swelling develops sudden acute pain - what do you think? A: Hemorrhage into a thyroid cyst - most common cause of sudden enlargement with pain. Also consider: De Quervain's subacute thyroiditis, or spontaneous hemorrhage into a cold nodule.

Q: A patient with a 20-year history of goitre presents with sudden rapid growth and difficulty breathing - what is your diagnosis? A: Anaplastic carcinoma arising in a longstanding multinodular goitre. This is a surgical emergency. Pre-existing goitre is a risk factor for anaplastic transformation.

Q: What is the significance of family history of phaeochromocytoma in a thyroid nodule patient? A: Raises the possibility of MEN 2A/2B syndrome. Medullary thyroid carcinoma is part of this syndrome. Serum calcitonin and RET mutation testing are essential before surgery, and urine catecholamines must be excluded before any operative intervention.

SECTION 5: CLINICAL EXAMINATION

5.1 General Examination

Before examining the neck - look at the whole patient:

Hyperthyroid Patient (Graves Disease)

Finding	Significance
Anxious, restless demeanor	Sympathetic overactivity
Fine tremor of outstretched hands	Thyrotoxicosis
Warm, moist, velvety skin	Peripheral vasodilation
Tachycardia (regular or irregular)	>100 bpm; AF in 10-15%
Lid lag (Von Graefe sign)	Sympathetic overactivity
Lid retraction (Dalrymple sign)	Upper lid above limbus - "stare"
Exophthalmos	Graves ophthalmopathy
Pretibial myxedema	Graves specific; indurated pinkish-brown plaques
Thyroid acropachy	Clubbing + periosteal reaction
Proximal muscle weakness	Thyrotoxic myopathy
Gynecomastia (males)	Sex hormone binding globulin changes

Graves Ophthalmopathy (Clinical Assessment)

NOSPECS Classification:

No signs/symptoms
Only signs (lid retraction, stare, lid lag)
Soft tissue involvement (periorbital edema, chemosis)
Proptosis (exophthalmos - >18 mm; measured by Hertel exophthalmometer)
Extraocular muscle involvement (diplopia)
Corneal involvement (exposure keratopathy)
Sight loss (optic nerve compression - EMERGENCY)

Hypothyroid Patient

Finding	Significance
Puffy face, periorbital edema	Mucopolysaccharide deposition
Dry, rough, yellowish skin (carotenemia)	Hypothyroidism
Coarse, brittle hair; loss of outer 1/3 eyebrow (Hertoghe sign)	Hypothyroidism
Bradycardia
Delayed relaxation of ankle jerks	Pathognomonic of hypothyroidism
Non-pitting edema	Myxedema
Husky voice

5.2 Local Examination - THE FOUR "S" Approach

INSPECTION

Ask patient to sit facing you in a well-lit room, neck slightly extended:

Observe:

Site: Midline (isthmus, pyramidal lobe, thyroglossal cyst) or lateral (thyroid lobe)
Size: Estimate in cm; compare to anatomical landmarks
Shape: Oval, irregular, multilobulated
Skin: Dilated veins (venous congestion from retrosternal extension), redness (thyroiditis), scar (previous surgery), fistula
Number of swellings: Single lobe, bilateral, isthmic
Pulsatility: Transmitted vs. expansile (thyroid vascular lesion is rare)
Movement with swallowing: Hallmark of thyroid swelling

SWALLOWING TEST:

Ask patient to take a sip of water and swallow while you observe
Thyroid swelling moves upward on swallowing
Positive in: Thyroid swellings, thyroglossal cysts, pre-laryngeal nodes (attached to pretracheal fascia)
Negative (does not move): Lipomas, sebaceous cysts, lymph nodes (unless stuck to thyroid)

TONGUE PROTRUSION TEST:

Ask patient to protrude the tongue upward
Specific for thyroglossal duct cysts (moves upward due to attachment to hyoid via thyroglossal tract)
Thyroid swellings do NOT move on tongue protrusion
Significance: Differentiates thyroglossal cyst from other midline swellings

PALPATION

Technique (Crile's Method - Examiner Favorite):

Stand behind the patient (surgeon's position)
Place both hands around the neck with fingertips meeting at midline
Ask patient to swallow
Systematically palpate both lobes and isthmus
Feel for size, shape, consistency, nodularity, tenderness, fixity, and lower border

Alternatively (S. Das approach):

Stand in front of the patient
Use thumb and fingers of both hands
Crile's (from behind) is preferred for examination

Findings to Note:

Feature	Benign	Malignant
Consistency	Soft/firm	Hard ("rock hard")
Surface	Smooth/nodular	Irregular
Borders	Well-defined	Ill-defined
Tenderness	Usually tender (thyroiditis)	Non-tender usually
Mobility	Mobile	Fixed to adjacent structures
Nodularity	Uninodular or multinodular	Irregular hard nodule
Lower border	Reachable	May extend retrosternally

Lahey's Method (for lower border palpation):

Patient tilts head to the opposite side (relaxes SCM)
Place index finger deep to the SCM
Feel for the lower border of the gland
If lower border cannot be felt = retrosternal extension

Assessment of Retrosternal Extension:

Cannot palpate lower border of thyroid
Dullness to percussion over upper sternum (Reverdin's sign - manubrium)
Pemberton's sign: Ask patient to raise both arms above head for 1 minute → facial plethora, distended neck veins, cyanosis = positive (thoracic inlet obstruction from retrosternal goitre)

Tracheal Assessment:

Kocher's test: Gently compress the lateral lobes between thumb and finger → if positive = stridor (indicates tracheal softening - tracheomalacia from long-standing goitre)
Assess tracheal position: midline vs. deviated (pushes trachea away; SVC obstruction doesn't push trachea)
Clinically assess for tracheal deviation

Cervical Lymph Nodes: Systematically palpate all cervical node groups:

Submental (Level IA)
Submandibular (Level IB)
Upper jugular/jugulodigastric (Level IIA, IIB)
Middle jugular (Level III)
Lower jugular (Level IV)
Posterior triangle (Level V)
Central neck / prelaryngeal / pretracheal / paratracheal (Level VI) - MOST IMPORTANT for thyroid
Supraclavicular (Level IV/V junction) - enlarged in thyroid cancer, breast, lung
Mediastinal (Level VII)

Enlarged Level VI (Delphian/central neck) nodes → MALIGNANCY

PERCUSSION

Percuss over the sternum (manubrium to lower sternum)
Dullness = retrosternal extension of goitre
Normal = resonant

AUSCULTATION

Place stethoscope bell over thyroid
Bruit (continuous systolic-diastolic murmur): Highly specific for Graves disease (hypervascular thyroid) - present in 80%
Differentiate from transmitted cardiac murmur (disappears on compression of common carotid artery)
Absence of bruit does NOT exclude Graves disease

5.3 Summary of Special Clinical Tests

Test	Technique	Positive Finding	Significance
Swallowing test	Sip water, swallow	Swelling moves up	Confirms thyroid origin; also thyroglossal cyst
Tongue protrusion test	Protrude tongue upward	Swelling moves up	Thyroglossal duct cyst specifically
Pemberton's sign	Raise both arms above head 1 min	Facial plethora + neck vein distension + cyanosis	Thoracic inlet obstruction from retrosternal goitre
Kocher's test	Compress lateral lobes	Stridor elicited	Tracheomalacia from long-standing goitre
Crile's method	Palpation from behind	Standard palpation	Best method for bimanual thyroid examination
Lahey's method	Head tilted opposite side, deep palpation	Cannot feel lower border	Retrosternal extension
Reverdin's sign	Percussion over manubrium	Dullness	Retrosternal goitre
Vocal cord assessment	Indirect laryngoscopy or nasofibroscopy	Cord paralysis	RLN injury (pre/post-op)

SECTION 6: DIFFERENTIAL DIAGNOSIS

Differential Diagnosis of Neck Swelling

Feature	Thyroid Swelling	Thyroglossal Cyst	Branchial Cyst	Lymph Node	Carotid Body Tumor
Age	Any	Child/young adult	Young adult	Any	30-60 years
Sex	F>M	Equal	Equal	Equal	F=M
Site	Anterior neck (midline/lateral)	Midline, below hyoid	Anterior triangle, level II/III	Cervical chain	At carotid bifurcation (angle of jaw)
Swallowing test	+ (moves up)	+ (moves up)	-	-	-
Tongue protrusion	-	+ (moves up)	-	-	-
Consistency	Variable	Soft/fluctuant	Soft/fluctuant	Variable	Firm, pulsatile
Pulsatility	- (transmitted only)	-	-	-	+ (expansile pulsation)
Bruit	+ in Graves	-	-	-	+ (AV shunting)
Transillumination	-	+	+	-	-
Horner syndrome	-	-	-	-	- (but compression possible)

SECTION 7: CASE PRESENTATION (UNIVERSITY EXAMINATION - 5 MINUTES)

Model Presentation Script

"Good morning, Sir/Ma'am. I present the case of Mrs. Savitha Reddy, a 38-year-old female school teacher, who presented with:

Chief Complaints: 1. Swelling in the front of the neck - 4 years 2. Rapid increase in size - 3 months 3. Discomfort on swallowing - 2 months 4. Hoarseness of voice - 3 weeks

On History: The swelling started 4 years ago as a small right-sided neck nodule and remained static, but has shown rapid growth over the last 3 months. The hoarseness of 3 weeks' duration is the most clinically significant symptom, suggesting possible involvement of the right recurrent laryngeal nerve.

There are no symptoms of hyperthyroidism or hypothyroidism. No history of neck irradiation. No family history of thyroid malignancy or MEN syndrome.

On General Examination: The patient is conscious, cooperative, and hemodynamically stable. She is afebrile, with pulse 78/min, BP 120/80 mmHg. No signs of thyrotoxicosis. No eye signs. No pretibial myxedema.

On Local Examination: There is a single swelling in the right lobe of the thyroid, measuring approximately 4 x 3 cm, with ill-defined borders. The swelling is hard in consistency, non-tender, with an irregular surface. It moves upward on swallowing (confirming thyroid origin) but does not move on tongue protrusion (excluding thyroglossal cyst). The lower border of the swelling is palpable. There is no retrosternal extension clinically.

On lymph node examination: I have found a single palpable, firm, non-tender node in Level III on the right side, approximately 1.5 cm in diameter.

My working diagnosis is: A right-sided solitary thyroid nodule, likely malignant - Papillary Thyroid Carcinoma, on the basis of: (1) hard consistency, (2) rapid growth, (3) hoarseness suggesting RLN involvement, and (4) ipsilateral cervical lymphadenopathy. I would like to investigate this patient to confirm the diagnosis and plan further management."

SECTION 8: INVESTIGATIONS

8.1 Investigation Algorithm

THYROID SWELLING
        │
        ▼
STEP 1: TSH (screening)
        │
   ┌────┴────┐
 Low TSH    Normal/High TSH
   │              │
   ▼              ▼
Free T3/T4     Thyroid Ultrasound (TI-RADS)
+Thyroid scan        │
(hot/cold)     ┌─────┴──────┐
               │            │
          TI-RADS 1-2    TI-RADS 3-5
               │            │
           Observe      FNA (Bethesda)
                             │
              ┌──────────────┼──────────────┐
           Beth I         Beth II      Beth III/IV/V/VI
         Repeat FNA       Follow up   Molecular testing/Surgery

8.2 Thyroid Function Tests

Test	Normal Range	Significance
TSH (first-line)	0.4 - 4.0 mIU/L	Low: hyperthyroid; High: hypothyroid
Free T4	0.8 - 1.8 ng/dL	Confirms thyroid status
Free T3	2.3 - 4.2 pg/mL	T3 toxicosis if T3 high with normal T4
Anti-TPO antibody	<35 IU/mL	Hashimoto's thyroiditis
Anti-thyroglobulin	<115 IU/mL	Hashimoto's, monitoring after thyroidectomy
TSH receptor antibody (TRAb)	Diagnostic for Graves disease	Differentiates Graves from toxic MNG
Serum calcitonin	<10 pg/mL	Medullary thyroid carcinoma; universal screening debated
Serum thyroglobulin	Follow-up marker after total thyroidectomy for DTC	Should be undetectable post-thyroidectomy

8.3 Ultrasound and TI-RADS

ACR TI-RADS Classification (2017) - Most Widely Used

Category	Features	Score	Malignancy Risk	Action
TR1	Benign (purely cystic)	0	<1%	No FNA
TR2	Not suspicious	0	<1%	No FNA
TR3	Mildly suspicious	3	~5%	FNA if ≥2.5 cm; follow if ≥1.5 cm
TR4	Moderately suspicious	4-6	~5-20%	FNA if ≥1.5 cm; follow if ≥1 cm
TR5	Highly suspicious	≥7	>20%	FNA if ≥1 cm; follow if ≥0.5 cm

Sonographic Features Scored in ACR TI-RADS:

Feature	Benign	Suspicious
Composition	Cystic, spongiform	Solid
Echogenicity	Hyperechoic, isoechoic	Hypoechoic, very hypoechoic
Shape	Wider than tall	Taller than wide
Margin	Smooth	Irregular, lobulated, extrathyroidal extension
Echogenic foci	Large comet-tail artifacts	Microcalcifications, rim calcifications

Examiner Pearl - TI-RADS vs. EU-TIRADS vs. K-TIRADS:

ACR TI-RADS (American): 5 categories, point-scoring system

EU-TIRADS (European): 5 categories, based on pattern recognition

K-TIRADS (Korean): Modified version

All aim to standardize FNA recommendations; EU-TIRADS used in 2023 ETA guidelines

8.4 FNAC and Bethesda Classification

The Bethesda System for Reporting Thyroid Cytopathology (2nd Edition, 2017)

Category	Diagnosis	Risk of Malignancy	Management
I	Non-diagnostic / Unsatisfactory	5-10%	Repeat FNA under US guidance
II	Benign	0-3%	Clinical follow-up + US in 1-2 years
III	Atypia of Undetermined Significance (AUS) / Follicular Lesion of Undetermined Significance (FLUS)	6-18%	Repeat FNA or molecular testing or lobectomy
IV	Follicular Neoplasm / Suspicious for Follicular Neoplasm	10-40%	Molecular testing or lobectomy
V	Suspicious for Malignancy	45-75%	Near-total thyroidectomy or lobectomy
VI	Malignant	97-99%	Total thyroidectomy (or lobectomy for low-risk)

Critical Limitation of FNAC: Cannot differentiate follicular adenoma from follicular carcinoma (requires histological evidence of capsular or vascular invasion - ONLY on excised specimen). This is why Bethesda IV mandates lobectomy.

8.5 Radioiodine Thyroid Scan (Scintigraphy)

Finding	Significance
Hot nodule (increased uptake)	Almost never malignant (<1%); toxic adenoma; no FNA needed if low TSH
Cold nodule (decreased uptake)	15-20% malignant risk; needs ultrasound + FNA
Warm nodule (equal uptake)	4-9% malignant risk
Patchy uptake	Multinodular goitre (endemic)
Diffuse increased uptake	Graves disease

Indications for thyroid scan:

Low TSH (to identify toxic nodule - hot nodule doesn't need FNA)
Before surgery for retrosternal goitre (to document ectopic thyroid tissue)
Follow-up post-thyroidectomy for DTC (whole body scan with RAI-131)

8.6 CT Scan / MRI

CT Neck and Chest (without contrast if RAI planned):

Assess extent of retrosternal extension
Airway compression (tracheal cross-sectional area)
Vascular involvement
Cervical lymph node mapping
Caution: Iodinated CT contrast delays RAI therapy by 2-3 months - use MRI or non-contrast CT if RAI planned

MRI:

Better soft tissue detail
No radiation, no contrast-RAI conflict
Assess RLN involvement, tracheal invasion, esophageal involvement
Used pre-operatively in complex cases

8.7 Other Investigations

Investigation	Indication
Indirect laryngoscopy / Nasofibroscopy	Pre-op vocal cord assessment (mandatory pre-thyroidectomy) + post-op assessment
PET-CT (FDG)	Thyroglobulin-positive, RAI-negative DTC recurrence; poorly differentiated carcinoma
RET mutation testing	All newly diagnosed medullary thyroid carcinoma (germline and somatic)
RET/PTC, BRAF, RAS, PAX8-PPARG	Molecular testing of indeterminate FNA (Bethesda III/IV) - ThyroSeq v3, Afirma GEC
Serum PTH	Pre and post thyroidectomy (if parathyroid compromise suspected)
Calcium (ionized)	Post-thyroidectomy monitoring (4 hourly for 24h)
Urine catecholamines	Before MTC surgery (rule out pheo in MEN2)

SECTION 9: MANAGEMENT

9.1 Evidence-Based Management Algorithm

Solitary Thyroid Nodule - ATA 2015 / ETA 2023 Algorithm

Solitary Thyroid Nodule Detected
            │
            ▼
    Measure TSH
            │
    ┌───────┴────────┐
  Low TSH         Normal TSH
    │                   │
    ▼                   ▼
Thyroid Scan      Ultrasound + TI-RADS
  (R/O hot nodule)
    │                   │
  Hot nodule         TI-RADS Score
  → treat toxic         │
    nodule    ┌─────────┴─────────┐
              │                   │
          TI-RADS 1-2         TI-RADS 3-5
          (low risk)          (moderate-high risk)
              │                   │
          No FNA              FNA (US-guided)
          US follow               │
                          Bethesda Classification
                                  │
           ┌──────────────────────┼──────────────────────┐
        Beth I              Beth II               Beth III/IV
       Repeat FNA          US follow-up           Molecular testing
                          3-5 years              OR Lobectomy
                                  │
                              Beth V/VI
                          Surgery (see below)

9.2 Medical Management

Antithyroid Drugs (for Hyperthyroidism)

Drug	Mechanism	Dose	Side Effects
Carbimazole	Blocks TPO enzyme → inhibits T3/T4 synthesis	30-60 mg/day initially; maintenance 5-15 mg/day	Agranulocytosis (0.3%), rash, hepatotoxicity
Propylthiouracil (PTU)	Blocks TPO + inhibits peripheral T4→T3 conversion	300-600 mg/day initially	Agranulocytosis, hepatic necrosis (preferred in pregnancy, thyroid storm)
Propranolol	Beta blocker - symptom control	40-80 mg TID/QID	Blocks sympathetic symptoms; does NOT affect thyroid hormone levels

Titration vs. Block-and-Replace:

Titration: Adjust ATD dose to keep patient euthyroid - standard method
Block-and-replace: Full blocking dose ATD + levothyroxine replacement - fewer dose adjustments needed

Remission after ATD in Graves (ATA 2016):

30-40% achieve remission after 12-18 months of ATD
Low TRAb, small goitre, mild disease = predictors of remission

Radioiodine (RAI) Therapy - I-131

Indications:

Graves disease (first-line in USA; not first-line in Europe for young patients)
Toxic multinodular goitre
Toxic adenoma
Post-surgical remnant ablation in DTC (high-risk and intermediate-risk)

Contraindications:

Pregnancy and breastfeeding (absolute)
Active severe Graves ophthalmopathy (relative - may worsen)
Unable to comply with radiation safety measures

Goal: Ablate thyroid → intentional hypothyroidism (acceptable outcome; treated with L-T4)

RAI in DTC Post-Thyroidectomy (ATA 2015):

High-risk disease: RAI recommended (reduces recurrence and cancer mortality)
Intermediate-risk: RAI generally favored
Low-risk: RAI not recommended routinely
Not recommended for papillary microcarcinoma (T1a, N0, M0)

Levothyroxine (L-T4)

Indications:

Hypothyroidism (primary replacement)
TSH suppression therapy post-thyroidectomy for DTC
Medical treatment of goitre (limited evidence - mainly in iodine-deficient areas)

TSH Suppression Targets in DTC (ATA 2015):

Risk Category	TSH Target
High-risk	<0.1 mIU/L
Intermediate-risk	0.1-0.5 mIU/L
Low-risk	0.5-2 mIU/L (after 5-10 years if disease-free)

9.3 Surgical Management

Extent of Surgery - Decision Algorithm

DECISION: EXTENT OF THYROID SURGERY
                │
    ┌───────────┼───────────┐
    │           │           │
Benign     Malignant    Hyperthyroid
disease     disease      disease
    │           │           │
    ▼           ▼           ▼
Lobectomy   See below   Total/near-total
or                      thyroidectomy
observation             (preferred for
                        definitive tx)

Extent of Surgery for Thyroid Cancer (ATA 2015 / ETA 2023)

Cancer Type	Extent of Surgery
PTC <1 cm, no ETE, no LN, no family history, no irradiation	Lobectomy (active surveillance also an option)
PTC 1-4 cm, low-risk, no ETE	Lobectomy or total thyroidectomy (based on patient preference)
PTC >4 cm, or ETE, or bilateral, or LN+	Total thyroidectomy
Follicular carcinoma (known pre-op rare)	Total thyroidectomy
Medullary carcinoma	Total thyroidectomy + central neck dissection (Level VI)
Anaplastic carcinoma	Near-total or total thyroidectomy if resectable; if unresectable - palliative
Graves disease	Total or near-total thyroidectomy
Toxic MNG	Total or near-total thyroidectomy
Large compressive goitre	Total or near-total thyroidectomy

Near-Total vs. Total Thyroidectomy (Bailey & Love / Schwartz debate):

Parameter	Total Thyroidectomy	Near-Total Thyroidectomy
Remnant	None	<1 g remnant left on side of better RLN/parathyroid
RAI ablation	Easier (no competing tissue)	Slightly more difficult
Hypothyroid risk	100%	100%
RLN injury risk	Higher (bilateral dissection)	Slightly lower
Current recommendation	Preferred (ATA 2015)	Acceptable alternative

Lymph Node Dissection for Thyroid Cancer

Dissection	Indication	Levels Cleared
Central neck dissection (CND)	MTC (always); PTC with cN1a; pT3-T4 PTC prophylactically (controversial)	Level VI (prelaryngeal, pretracheal, paratracheal bilateral)
Ipsilateral lateral neck dissection	cN1b (clinically positive lateral nodes)	Levels II, III, IV, V
Bilateral lateral neck dissection	Bilateral cN1b	Levels II-V bilateral

ATA 2015 on Prophylactic CND in PTC: Prophylactic CND (in cN0) is "not routinely recommended" for T1-T2 PTC due to increased morbidity without proven survival benefit. May be considered in T3-T4 disease. MTC = always do bilateral CND.

SECTION 10: OPERATIVE TECHNIQUE

10.1 Total Thyroidectomy - Step by Step

Preoperative Assessment

Indirect laryngoscopy - document bilateral cord mobility (MANDATORY pre-op)
Thyroid function euthyroid state (Carbimazole + beta-blocker in toxic goitre)
Lugol's iodine (5 drops TDS for 10 days pre-op in Graves disease) - reduces vascularity
Blood group and crossmatch
Calcium and PTH baseline

Patient Positioning

Supine, neck extended using a sandbag/thyroid bolster under shoulders
Arms tucked at sides
Head ring to prevent movement
Table in reverse Trendelenburg (15-20°) to reduce venous bleeding

Incision - Kocher's Collar Incision

Transverse incision 2 cm above sternal notch, in a skin crease
Length: 5-7 cm (longer for large goitres, retrosternal extension)
Should lie within Langer's lines for cosmesis
Carried through skin, subcutaneous fat, platysma

Raising Subplatysmal Flaps

Superior flap: to thyroid notch of thyroid cartilage
Inferior flap: to sternal notch
Plane: between platysma and deep cervical fascia

Opening Midline (Linea Alba of Neck)

Divide along midline between strap muscles (sternohyoid, sternothyroid)
Avoid damage to strap muscles (retract laterally)
If necessary for large goitre - divide strap muscles (sternothyroid) transversely in upper 1/3 (preserves nerve supply from ansa cervicalis which enters lower 2/3)

Mobilization of Thyroid Lobe

Divide middle thyroid vein first (key step - provides lateral mobilization)
Divide superior thyroid vessels individually close to upper pole (preserve EBSLN)
Identify and trace RLN in tracheoesophageal groove
Ligate inferior thyroid artery branches close to thyroid capsule (preserve parathyroid blood supply)
Identify and preserve parathyroid glands
Divide Berry's ligament carefully (RLN may pass through it)
Divide isthmus and pyramidal lobe

RLN Identification - Systematic Approach (S. Das / Bailey & Love)

Three consistent landmarks for RLN:

Tracheoesophageal groove - where RLN typically lies
Tubercle of Zuckerkandl - RLN lies medial to it
Inferior cornu of thyroid cartilage - where RLN enters larynx

Visual characteristics of RLN:

White glistening nerve, about 1-2 mm diameter
Runs superiorly between trachea and esophagus
May branch (anterior branch = abductor; posterior branch = adductor) - in 40% cases before entering larynx

Intraoperative Neuromonitoring (IONM):

Electromyographic monitoring of vocalis muscle
Endotracheal tube with recording electrodes
Standard of care in high-risk cases (re-do surgery, large goitre, malignancy)
Provides continuous feedback; positive signal = RLN intact
"Loss of signal" alerts surgeon immediately

Parathyroid Preservation Protocol

Identify all 4 glands early
Superior parathyroids: at cricothyroid joint level, posterior to thyroid
Inferior parathyroids: anterior to RLN, at lower pole, may be in fat
Preserve blood supply - maintain fat pad
If gland color changes (darkens/becomes gray) = devascularized → autotransplant
Autotransplant technique: Confirm parathyroid tissue on frozen section → mince into 1 mm fragments → implant into pockets in SCM muscle (or brachioradialis) → mark with non-absorbable suture or metal clip

Hemostasis and Closure

Meticulous hemostasis (bipolar diathermy, clips, ligatures)
Check for bleeding, especially with Valsalva maneuver
Suction drain (Redivac/Blake) in thyroid bed (optional - not universally recommended)
Close strap muscles in midline
Close platysma (2/0 Vicryl)
Subcuticular suture or skin clips for skin
Total operative time: 90-180 minutes

SECTION 11: COMPLICATIONS

11.1 Complications of Thyroidectomy

Immediate (0-24 hours)

Complication	Incidence	Mechanism	Management
Hemorrhage / Neck hematoma	0.3-1%	Slipped ligature, venous ooze	OPEN WOUND AT BEDSIDE IMMEDIATELY → secure airway → return to OR
Airway obstruction	Rare	Hematoma compression, bilateral RLN injury, tracheomalacia	Intubation / tracheostomy
Thyroid storm	<1%	In poorly prepared thyrotoxic patient	ICU: beta blockers, PTU, Lugol's iodine, hydrocortisone, cooling

Critical Protocol for Post-Thyroidectomy Neck Hematoma: Opening the wound at bedside IMMEDIATELY (even in ward, even without anesthesia) is LIFE-SAVING. Delay causes asphyxia from progressive tracheal compression.

Early (24-72 hours)

Complication	Incidence	Mechanism	Management
Hypocalcemia (transient)	20-30% after TT	Parathyroid bruising, devascularization	Oral/IV calcium, vitamin D
Hypoparathyroidism (permanent)	1-4% after TT	Loss of parathyroid tissue	Lifelong calcium + calcitriol
RLN injury (temporary)	3-5%	Neuropraxia/stretching	Spontaneous recovery in 6-12 months
RLN injury (permanent)	<1% (experienced surgeons)	Section/devascularization	Speech therapy; thyroplasty
EBSLN injury	1-28% (often subclinical)	Ligation near upper pole	Voice therapy
Wound infection	<1%	Standard surgical	Antibiotics
Seroma	3-5%	Fluid collection in dead space	Aspiration, compression

Late Complications

Complication	Management
Hypothyroidism (expected after total thyroidectomy)	Lifelong L-T4 replacement
Recurrence of goitre or cancer	Re-operation (high risk) or RAI
Hypertrophic scar / Keloid	Silicone gel, steroid injection
Recurrence of hyperthyroidism after subtotal	Re-operate or RAI

11.2 Hypocalcemia Management Flowchart

Post-Thyroidectomy
        │
        ▼
    Monitor symptoms (tingling, perioral
    numbness, Trousseau, Chvostek)
        │
        ▼
    Check Calcium (ionized) at 4h, 12h, 24h
        │
    ┌───┴───┐
  Symptomatic  Asymptomatic
  or Ca <1.9    Ca >2.0
       │             │
       ▼             ▼
  IV Calcium    Oral calcium + Calcitriol
  (10% CaCl₂    (Calcium carbonate 1.5g TDS
  or gluconate)  + Calcitriol 0.5-1 mcg OD)
       │
       ▼
  Reassess at 4-6h
       │
    Persistent?
  Check PTH
  (if <10 pg/mL
  = hypoparathyroidism)
       │
       ▼
  Long-term calcium + calcitriol
  (Teriparatide if available)

11.3 Thyroid Storm (Thyrotoxic Crisis)

Precipitants: Surgery in unprepared thyrotoxic patient, infection, trauma, RAI in uncontrolled thyrotoxicosis.

Clinical Features (Burch-Wartofsky Score >45 = likely thyroid storm):

High fever (>40°C)
Tachycardia (>140 bpm)
Agitation, delirium, coma
Diarrhea, vomiting
Cardiac failure, AF

Management (Mnemonic: BSTII):

Beta blockers (propranolol 60-80 mg PO or IV) - first to give
Steroids (hydrocortisone 300 mg IV) - block T4→T3 conversion
Thionamides (PTU 600 mg stat, then 200-300 mg 6 hourly - preferred over carbimazole)
Iodine (Lugol's iodine - given at least 1 hour AFTER PTU to prevent new hormone synthesis)
Intensive supportive care (cooling, rehydration, treat precipitant)

SECTION 12: THYROID MALIGNANCY - COMPREHENSIVE DISCUSSION

12.1 Classification of Thyroid Malignancy

Type	Frequency	Origin	5-year Survival	Key Feature
Papillary	80-85%	Follicular cells	97-99%	Best prognosis; lymph node spread; Orphan Annie eye nuclei
Follicular	10-15%	Follicular cells	91-95%	Hematogenous spread; requires capsular/vascular invasion for diagnosis
Hurthle cell (Oncocytic)	3-5%	Follicular cells (oxyphilic)	85-90%	RAI-resistant; aggressive
Poorly differentiated	2-4%	Follicular cells	50-60%	Between well-differentiated and anaplastic
Anaplastic	1-2%	Follicular cells	<10% (median survival 6 months)	Most aggressive human malignancy
Medullary	3-5%	C cells (parafollicular)	75-85%	Calcitonin; RET mutation; amyloid; MEN2
Lymphoma	<5%	Lymphoid	Variable	Associated with Hashimoto's; MALT/DLBCL
Metastatic	Rare	Kidney, breast, lung, melanoma	Poor	Multiple bilateral deposits

12.2 Papillary Thyroid Carcinoma (PTC) - Detailed

Gross Pathology: Unencapsulated, infiltrative, sometimes calcified (psammoma bodies grossly visible)

Histology (S. Das, Bailey & Love):

Orphan Annie eye nuclei (empty, ground glass, optically clear nuclei) - pathognomonic
Nuclear grooves and nuclear pseudoinclusions
Psammoma bodies (concentric calcifications, in 50%) - pathognomonic of PTC
Papillary architecture
May show sclerotic stroma

Molecular Markers:

BRAF V600E mutation: 40-70% of PTC; associated with higher recurrence, aggressive behavior, loss of RAI avidity
RET/PTC rearrangements: More in radiation-induced PTC
RAS mutations: More in follicular variant PTC

Variants of PTC:

Variant	Clinical Significance
Classic papillary	Standard behavior
Follicular variant	Better prognosis; NIFTP if encapsulated and non-invasive
Tall cell variant	More aggressive; BRAF+
Columnar cell variant	Aggressive
Diffuse sclerosing variant	Young patients; extensive lymph node involvement; BRAF-
Hobnail variant	Aggressive; high risk recurrence
Papillary microcarcinoma	≤1 cm; excellent prognosis; active surveillance acceptable

NIFTP (Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features):

Previously called "encapsulated follicular variant PTC"
Reclassified 2016 as NIFTP (Nikiforov et al., NEJM 2016)
Behaves as benign - near-zero risk of recurrence
Changes Bethesda risk of malignancy (excluded from malignant category)
Does NOT require total thyroidectomy or RAI

12.3 Follicular Thyroid Carcinoma (FTC) - Detailed

Key Difference from PTC:

FNA CANNOT diagnose FTC - requires histology of the entire capsule
Diagnosis requires: capsular invasion (full-thickness) AND/OR vascular invasion

Minimally invasive FTC vs. Widely invasive FTC:

Feature	Minimally invasive	Widely invasive
Capsular invasion	Present	Extensive
Vascular invasion	Absent or <4 foci	≥4 foci
Prognosis	Excellent	Poor
Treatment	Lobectomy may suffice	Total thyroidectomy + RAI

Spread: Hematogenous (blood-borne) spread is characteristic - to lungs, bone (osteolytic), brain. Contrast with PTC which spreads lymphogenously.

12.4 Medullary Thyroid Carcinoma (MTC) - Detailed

Origin: C cells (parafollicular cells) - secrete calcitonin

Types:

Type	Frequency
Sporadic	75%
Familial (MEN2A)	20%
MEN2B	5%
Familial MTC (non-MEN)	Rare

Biochemical Markers:

Serum calcitonin: Tumor marker for MTC; correlates with disease burden; universal screening recommended by ETA (controversial in ATA)
CEA: Also elevated; not specific; prognosis marker
Pentagastrin stimulation test: For equivocal calcitonin levels

RET Proto-oncogene (Chromosome 10q11.2):

ALL newly diagnosed MTC should have germline RET testing
Codon 918 mutation (MEN2B) = most aggressive
Codon 634 mutation (MEN2A) = moderate risk
Codon 768, 790, 791 = low risk

MEN2A Components:

Medullary thyroid carcinoma (95%)
Phaeochromocytoma (50%)
Hyperparathyroidism (25%)

Management of MTC:

Rule out phaeochromocytoma (urine metanephrines/catecholamines) BEFORE thyroid surgery
Total thyroidectomy + bilateral central neck dissection (Level VI) - all cases
Lateral neck dissection if lateral LN+ or calcitonin >200 pg/mL
RAI: NOT effective (C cells do not trap iodine)
External beam radiotherapy for local control
Tyrosine kinase inhibitors (Vandetanib, Cabozantinib) for advanced/metastatic MTC
RET inhibitors: Selpercatinib (LOXO-292) - FDA approved 2020 for RET-mutant MTC

12.5 Anaplastic Thyroid Carcinoma (ATC)

Median age: 65 years; M=F
Rapidly enlarging, hard, fixed neck mass; most patients present with local invasion
Symptoms: stridor, dysphagia, neck pain
Histology: Undifferentiated cells (spindle, giant, squamoid)
All ATC = Stage IV by definition
Immunohistochemistry: Negative for Tg, TTF-1; positive for PAX8 (in 50-60%)

Treatment:

If resectable (rare): Surgery + external beam RT + chemotherapy (doxorubicin)
If unresectable (majority): Palliative intent
BRAF V600E mutation in 40-50% of ATC → BRAF+MEK inhibitor (Dabrafenib + Trametinib) - FDA approved 2018 - significant survival benefit
Immunotherapy (Pembrolizumab) for PD-L1 positive ATC

SECTION 13: VIVA QUESTIONS (100+)

13.1 Anatomy Viva

Q1. What is Berry's ligament? A: The posterior suspensory ligament of the thyroid, formed by the condensation of the pretracheal fascia (false capsule), attaching the posteromedial aspect of the thyroid to the tracheal rings 2-4. The RLN passes deep to it or through its substance in 25% of cases. It must be carefully divided during thyroidectomy.

Q2. What is the Tubercle of Zuckerkandl? A: A posterolateral extension of the lateral lobe of the thyroid, present in 60-80% of cases. It is found at the junction of the upper and middle thirds of the lobe. It is an important surgical landmark - the RLN lies medial to it as it enters the larynx. When the tubercle is prominent, it can obscure the RLN.

Q3. Why is the middle thyroid vein divided first in thyroidectomy? A: The middle thyroid vein is the first structure divided to provide lateral mobilization of the lobe, enabling subsequent safe identification of the RLN. It runs directly from the lateral aspect of the thyroid to the internal jugular vein with no corresponding artery.

Q4. What is the relationship of RLN to the inferior thyroid artery? A: Variable: RLN passes anterior to ITA in 37%, posterior to ITA in 42%, and between branches of ITA in 20%. This variability makes routine identification of the RLN essential rather than relying on anatomical "rules."

Q5. What is a non-recurrent laryngeal nerve? A: A rare variant (0.5-1%) occurring on the right side, where the nerve runs directly from the vagus to the larynx without looping. Associated with an anomalous right subclavian artery (arteria lusoria). Surgically dangerous because it can be mistaken for a blood vessel and divided.

Q6. Where do the superior and inferior parathyroid glands arise from embryologically? A: Superior parathyroids from the 4th pharyngeal pouch. Inferior parathyroids from the 3rd pharyngeal pouch (same as thymus). Because the inferior parathyroids travel a longer embryological distance (with the thymus), they are more variable in position.

Q7. What is the EBSLN and what is the Cernea classification? A: The external branch of the superior laryngeal nerve supplies the cricothyroid muscle (tensor of vocal cords). It runs with the superior thyroid artery. Cernea classified its relationship to the STA: Type 1 - crosses STA >1 cm above upper pole (safe); Type 2a - within 1 cm; Type 2b - below upper pole (most dangerous). Injury causes loss of voice pitch, projection, and fatigue.

13.2 Examination Viva

Q8. How do you differentiate a thyroid swelling from other neck swellings? A: Key tests: (1) Swallowing test - thyroid swelling moves upward. (2) Tongue protrusion test - thyroid does NOT move (distinguishes from thyroglossal cyst which moves up on tongue protrusion). The movement on swallowing is because the thyroid is enclosed in the pretracheal layer of deep cervical fascia, which is attached to the thyroid cartilage above, and moves up with the larynx during swallowing.

Q9. What is Pemberton's sign? A: Ask patient to raise both arms above the head for 1-2 minutes. A positive sign is facial plethora, cyanosis, and distension of neck veins due to compression of the thoracic inlet (SVC, jugular veins, trachea) by a retrosternal goitre.

Q10. What is Kocher's test? A: Gentle lateral compression of the thyroid lobes between thumb and fingers. If this produces stridor, it indicates tracheomalacia (softening of tracheal rings) from prolonged compression by longstanding goitre. Suggests that surgical removal of the goitre may be followed by tracheal collapse (may need tracheal reinforcement or tracheostomy).

Q11. What is Crile's method of thyroid examination? A: The surgeon stands behind the seated patient and places both hands around the neck with fingertips meeting in the midline. The patient is asked to swallow while the examiner palpates. This bimanual technique allows simultaneous assessment of both lobes and is the preferred method for systematic thyroid examination.

Q12. What is Lahey's method? A: The patient tilts the head toward the side being examined (relaxing the SCM). The examiner's index finger is placed deep behind the SCM to feel the lower border of the thyroid. If the lower border cannot be palpated, retrosternal extension is suspected.

13.3 Investigation Viva

Q13. What is the Bethesda system and why was it introduced? A: The Bethesda System for Reporting Thyroid Cytopathology (1st edition 2007, 2nd edition 2017) was introduced to standardize reporting of thyroid FNA results and provide risk of malignancy estimates for each category (I-VI). It allows clinicians to make evidence-based management decisions. Previously, variable cytological terminology made clinical management inconsistent.

Q14. Why can't FNA differentiate follicular adenoma from follicular carcinoma? A: Follicular carcinoma is defined by histological evidence of capsular invasion (full-thickness penetration) or vascular invasion of the fibrous capsule - features that CANNOT be assessed on cytological specimens which contain only cells, not architectural relationships. This is why Bethesda IV (Follicular Neoplasm) mandates surgical excision (lobectomy) as the only way to make a definitive diagnosis.

Q15. What is NIFTP and why is it important? A: NIFTP (Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) was introduced by Nikiforov et al. in 2016. It reclassifies what was previously called "encapsulated follicular variant of PTC" as a borderline/very low-risk neoplasm. Key criteria: encapsulated or clearly demarcated, follicular growth pattern, PTC-like nuclear features, no invasion, no psammoma bodies, no vascular invasion. Its recognition has: (1) reduced overtreatment, (2) lowered the malignancy risk in Bethesda categories III and IV, (3) made lobectomy adequate treatment.

Q16. When do you order serum calcitonin? A: Before any thyroid surgery (universal screening debated - supported by ETA, not routinely recommended by ATA in all nodules). Mandatory in: (1) all thyroid nodules with family history of MTC or MEN2, (2) all patients with suspicious cytology, (3) all patients with elevated calcium or other MEN2 features. Calcitonin >100 pg/mL is highly suspicious for MTC. Stimulated calcitonin (pentagastrin test) detects C cell hyperplasia (pre-malignant).

Q17. What is the role of molecular testing in thyroid nodules? A: Used for Bethesda III and IV (indeterminate) nodules to risk-stratify and reduce unnecessary surgery. Two main platforms:

Afirma Gene Expression Classifier (GEC): "Rule out" test - if negative (benign), surgery can be avoided.
ThyroSeq v3: "Rule in" test - detects specific mutations (BRAF, RAS, RET/PTC, PAX8-PPARG, TERT promoter, etc.) with high sensitivity and specificity.
Positive BRAF V600E = proceed to total thyroidectomy
Negative mutation panel = lobectomy or observation

13.4 Operative Viva

Q18. What are the steps of identifying the RLN? A: (1) Divide middle thyroid vein and retract lobe medially. (2) Identify tracheoesophageal groove. (3) Find Tubercle of Zuckerkandl - RLN lies medial to it. (4) Trace from inferior aspect upward OR from entry into larynx (inferior cornu of thyroid cartilage) downward. (5) Use IONM (intraoperative neuromonitoring) in complex cases. (6) Never clamp, cauterize, or cut anything in the tracheoesophageal groove without visual confirmation.

Q19. How do you preserve the parathyroid glands during thyroidectomy? A: (1) Early identification of all 4 glands. (2) Preserve fat pad around glands. (3) Ligate ITA branches at capsule (not as a main trunk) to preserve parathyroid vascularity. (4) Check color - normal tan/yellow-brown. (5) If vascular compromise occurs → immediate autotransplant (freeze section confirmation → mince 1 mm fragments → implant in SCM pockets). (6) Mark autotransplanted tissue with non-absorbable suture.

Q20. Why is the superior thyroid artery ligated close to the upper pole? A: To avoid injury to the EBSLN, which runs with the STA but diverges above the upper pole in type 2b (most common Cernea type). Ligating individually and close to the gland ensures the nerve has already separated from the vessels.

Q21. How do you handle a neck hematoma post-thyroidectomy? A: SURGICAL EMERGENCY. Protocol: (1) DO NOT wait for OR. (2) Open wound IMMEDIATELY at bedside - remove sutures and clips at skin and platysma to release pressure on trachea. (3) Call anesthesia. (4) Secure airway (intubation/emergency tracheostomy if needed). (5) Transfer to OR for definitive hemostasis under GA. (6) The swallowing of blood may mask external evidence of bleeding - low threshold for wound opening.

Q22. What is the Sistrunk operation? A: Operation for thyroglossal duct cyst. Comprises: (1) Excision of the thyroglossal cyst, (2) Excision of the central portion of the hyoid bone (to remove the embryological thyroglossal tract passing through it), (3) Coring out of a 1-2 cm cylinder of tongue base muscle up to the foramen caecum. Recurrence rate without hyoid excision: 30-50% vs. <3% with the Sistrunk operation.

13.5 Emergency Viva Scenarios

Q23. You are on call and a patient develops stridor 2 hours after total thyroidectomy. What do you do? A: This is neck hematoma causing airway obstruction - LIFE-THREATENING EMERGENCY. Step 1: Call for help (senior surgeon, anesthesia, OR team). Step 2: Open wound IMMEDIATELY at bedside - remove ALL sutures including deep sutures to decompress the hematoma. This is done without anesthesia if necessary. Step 3: Airway - if stridor not relieved → oral/nasotracheal intubation (may be very difficult with distorted anatomy - call for experienced anesthesiologist) → if fails → emergency cricothyrotomy or surgical tracheostomy. Step 4: Transfer to OR for hemostasis under general anesthesia. Do NOT administer sedation before opening the wound (removes respiratory drive).

Q24. A patient presents 6 months post-total thyroidectomy for PTC with rising thyroglobulin but negative RAI scan. What do you suspect and how do you manage? A: Thyroglobulin-positive, RAI-scan negative DTC (Tg+ RAI- disease). This typically indicates: (1) Poorly differentiated/dedifferentiated metastatic PTC, (2) Cervical or distant metastases with loss of iodine-avidity (BRAF mutation causes loss of NIS expression). Management: (1) FDG-PET scan (metabolically active dedifferentiated tumor takes up glucose), (2) High-dose RAI after TSH stimulation (may convert some lesions to RAI-avid), (3) BRAF inhibitor (Vemurafenib) can temporarily restore RAI avidity - "redifferentiation therapy," (4) Tyrosine kinase inhibitors (Sorafenib, Lenvatinib) for progressive metastatic DTC.

13.6 Specimen Viva

Q25. You are shown a hemithyroidectomy specimen. What do you look for? A: (1) Size and weight of the lobe. (2) External surface - capsule intact or breached? (3) On sectioning - number, size, and consistency of nodules. (4) Color - white/gray (malignant), brown (adenoma), green/translucent (colloid), gelatinous (thyroiditis). (5) Calcifications - psammoma bodies suggest PTC. (6) Any lymph nodes in the specimen. (7) Normal parathyroid tissue? Send for frozen section. (8) Isthmus included?

13.7 Histopathology Viva

Q26. What are the histological features of papillary thyroid carcinoma? A: (1) Orphan Annie eye nuclei - empty, optically clear (ground glass) nuclei due to fine chromatin dispersal. (2) Nuclear grooves - longitudinal folding of nuclear membrane. (3) Nuclear pseudoinclusions - intranuclear cytoplasmic inclusions. (4) Psammoma bodies - concentric calcified lamellations (in 50%). (5) Papillary architecture (finger-like projections with fibrovascular cores). (6) Fibrosclerosis, lymphocytic infiltrate.

Q27. How do you histologically diagnose follicular carcinoma? A: Evidence of: (1) Capsular invasion - full-thickness penetration of the fibrous capsule by tumor cells (not just irregularity or buds into capsule). (2) Vascular invasion - tumor thrombus within capsular or extracapsular vessels (not just vessels within tumor). Absence of these features = follicular adenoma, even if FNA suggested follicular neoplasm.

SECTION 14: FLOWCHARTS

Approach to Thyroid Swelling

THYROID SWELLING
        │
        ▼
History + Examination
        │
    ┌───┴───┐
 Toxic    Non-toxic
    │          │
    ▼          ▼
TSH, T3, T4    TSH
Antibodies      │
Scan        ┌──┴──┐
        Normal    High
            │       │
           US     Hashimoto?
         TI-RADS   Hypothyroid
            │
         FNA (Bethesda)
            │
    ┌───────┼───────┐
  I/II    III/IV    V/VI
  Follow  Molecular  Surgery
          /Lobectomy

Postoperative Monitoring After Total Thyroidectomy

Post-Total Thyroidectomy
        │
        ├── Airway (RLN - laryngoscopy at 48h)
        ├── Calcium (4h, 12h, 24h ionized Ca)
        ├── PTH (at 6h - PTH <15 = hypoparathyroidism risk)
        ├── Drain output (hematoma watch)
        ├── Voice assessment
        └── TSH + thyroglobulin at 6-8 weeks
                │
           DTC follow-up:
           • L-T4 (TSH suppression)
           • Tg + anti-Tg at 6 months
           • Neck US at 6-12 months
           • RAI scan (if high-risk or Tg rising)

SECTION 15: MIND MAPS

Mind Map 1: Thyroid Swelling - Rapid Revision

                    THYROID SWELLING
                           │
          ┌────────────────┼────────────────┐
      BENIGN           MALIGNANT        TOXIC
          │                │                │
    Follicular           PTC 80%        Graves
    adenoma              FTC 10%        Toxic MNG
    Colloid cyst         MTC 5%         Toxic adenoma
    MNG                  ATC 1%
    Thyroiditis          Lymphoma

Mind Map 2: PTC Mnemonics

Features of PTC (POPCORN):

Psammoma bodies
Orphan Annie nuclei
Papillary architecture
Calcitonin-negative (NOT calcitonin - that's MTC)
Occult presentation (microcarcinoma common)
RLN involvement in advanced disease
Node spread (cervical lymph nodes - characteristic)

Risk factors for thyroid malignancy (HIRF):

History of radiation to neck
Increasing size rapidly
RLN palsy (hoarseness)
Family history (PTC, MTC, MEN)

SECTION 16: HIGH-YIELD MS/DNB PEARLS

16.1 Examiner Favorites

"What moves on swallowing?" - Everything in the pretracheal fascia (thyroid, thyroglossal cyst, prelaryngeal nodes, but NOT branchial cysts, lymph nodes, lipomas)
"What moves on tongue protrusion?" - Only thyroglossal duct cysts (and lingual thyroid)
"What is the most dangerous step in thyroidectomy?" - Division of Berry's ligament (RLN risk) and ligation of superior thyroid artery (EBSLN risk)
"What is the first thing you do in post-thyroidectomy airway compromise?" - Open the wound at bedside. OPEN THE WOUND. OPEN THE WOUND. Not call for help. Not give oxygen. OPEN THE WOUND FIRST.
"Why can't FNA diagnose follicular carcinoma?" - Requires histological capsular and vascular invasion assessment
"What is the AJCC 8th edition change?" - Age cutoff moved from 45 to 55 years for DTC staging
"What is NIFTP?" - Noninvasive follicular thyroid neoplasm with papillary-like nuclear features; previously encapsulated follicular variant PTC; behaves benign; lobectomy adequate
"What is the Wolff-Chaikoff effect?" - Paradoxical inhibition of thyroid hormone synthesis by large doses of iodine (used in Lugol's preparation for Graves surgery)
"What is the role of Lugol's iodine before thyroid surgery in Graves disease?" - Given 10 days pre-op (Lugol's iodine 5-8 drops TDS) - reduces vascularity and friability of the gland, making dissection safer (reduces blood loss)
"What is thyroglobulin used for post-thyroidectomy?" - Tumor marker for differentiated thyroid cancer (PTC/FTC) follow-up. Should be undetectable after total thyroidectomy and RAI. Rising Tg suggests recurrence. Not useful for medullary or anaplastic cancer.

16.2 Common Candidate Mistakes

Mistake	Correct Answer
Saying "cold nodule = malignant"	Cold nodule has 15-20% malignancy risk, not 100%. Hot nodule has <1% risk.
Saying FNA can diagnose follicular carcinoma	FNA cannot - requires histology
Forgetting pre-op laryngoscopy	MANDATORY before any thyroid surgery
Not excluding phaeochromocytoma before MTC surgery	MEN2A - pheo must be excluded FIRST
Saying levothyroxine reduces goitre	Evidence is weak; mainly useful in iodine-deficient areas
Dividing strap muscles at the lower 1/3	Divide in upper 1/3 to preserve ansa cervicalis nerve supply
Saying bilateral RLN injury causes hoarseness	Bilateral complete RLN injury causes aphonia + respiratory distress (emergency)

16.3 Instrument Viva

Instruments used in thyroid surgery:

Kocher's artery forceps - designed by Emil Kocher; used for clamping thyroid vessels
Lane's tissue-holding forceps - for holding thyroid
Lahey's thyroid-holding forceps - curved; for holding and rotating thyroid
Right-angled artery forceps - for passing ligatures around vessels in Berry's ligament area
Bipolar diathermy - for hemostasis near the RLN
Harmonic scalpel / LigaSure - vessel sealing devices (reduces operative time, less thermal spread)
Nerve stimulator - intraoperative neuromonitoring probe
Redivac drain - closed suction drain for thyroid bed

SECTION 17: FINAL RAPID REVISION SHEET

ONE-PAGE RAPID REVISION

TOP 20 ONE-LINERS

Thyroid arises from foramen caecum - descends via thyroglossal duct.
Thyroglossal cyst moves on tongue protrusion; thyroid swelling does not.
Berry's ligament = RLN danger zone (25% of cases - nerve passes through it).
Middle thyroid vein = first structure divided in thyroidectomy.
Cold nodule = 15-20% malignancy risk; hot nodule = <1%.
FNA cannot diagnose follicular carcinoma (needs capsular/vascular invasion on histology).
Bethesda IV = Follicular Neoplasm = Lobectomy (not observation).
NIFTP - reclassified from encapsulated follicular PTC - behaves benign.
PTC spreads lymphogenously; FTC spreads hematogenously.
Orphan Annie nuclei + psammoma bodies = PTC.
Calcitonin = tumor marker for medullary thyroid carcinoma.
All MTC = RET mutation testing + pheo exclusion before surgery.
AJCC 8th edition: age cutoff for DTC staging moved from 45 → 55 years.
Cernea Type 2b EBSLN = most dangerous (crosses STA below upper pole).
Pemberton's sign = retrosternal goitre causing thoracic inlet obstruction.
Kocher's test positive = tracheomalacia (long-standing goitre).
Bilateral RLN injury = aphonia + stridor + emergency (NOT hoarseness).
Post-thyroidectomy hematoma = open wound at bedside IMMEDIATELY.
Post-thyroidectomy: monitor Ca at 4h, 12h, 24h + PTH at 6h.
Lateral aberrant thyroid = does NOT exist = always metastatic PTC in LN.

TOP 10 EXAMINER TRAPS

"Hoarseness = bilateral RLN injury" - WRONG. Hoarseness = unilateral. Bilateral = stridor/aphonia.
"All cold nodules are malignant" - WRONG. 80-85% of cold nodules are benign.
"FNA Bethesda I = benign" - WRONG. Bethesda I = non-diagnostic (inadequate sample). Bethesda II = benign.
"Lugol's iodine used to suppress thyroid function" - WRONG. It reduces vascularity (Wolff-Chaikoff effect) pre-op; does NOT definitively treat hyperthyroidism.
"Inferior thyroid artery should be ligated as a main trunk to preserve parathyroids" - WRONG. Ligate BRANCHES close to capsule to preserve parathyroid blood supply from the main trunk.
"Subtotal thyroidectomy preferred for Graves disease" - OUTDATED. ATA 2016 recommends total/near-total thyroidectomy for definitive surgical treatment of Graves.
"RAI is first-line for all hyperthyroidism" - WRONG. In Europe/India, antithyroid drugs are often first-line. RAI is preferred in USA. Decision is patient-specific.
"Active surveillance is never appropriate for thyroid cancer" - WRONG. Active surveillance is an acceptable option for papillary microcarcinoma (<1 cm, no ETE, no LN, no distant met) - ATA 2015.
"Thyroglobulin is a useful marker for medullary carcinoma follow-up" - WRONG. Thyroglobulin is produced by follicular cells only. MTC follow-up uses calcitonin and CEA.
"Prophylactic central neck dissection is standard for all PTC" - CONTROVERSIAL. ATA 2015 does NOT routinely recommend prophylactic CND for T1-T2, cN0 PTC due to increased morbidity without survival benefit.

TOP 10 THYROID EXAMINATION PEARLS

Always ask the patient to swallow - confirm thyroid origin.
Tongue protrusion - if swelling moves = thyroglossal cyst.
Stand behind the patient (Crile's method) for bimanual palpation.
Always palpate for lymph nodes (Level VI first - Delphian node).
Check for Pemberton's sign in large or suspicious retrosternal goitre.
Auscultate for bruit over the thyroid (Graves disease).
Check eyes for proptosis, lid retraction, lid lag, chemosis.
Check pretibial area for myxedema (Graves specific).
Assess voice before and document clearly (hoarseness = RLN flag).
Always complete general examination - pulse, hands (tremor, warmth), reflexes (delayed relaxation in hypothyroid).

TOP 10 OPERATIVE PEARLS

Euthyroid state MANDATORY before elective thyroid surgery.
Pre-op vocal cord assessment by flexible laryngoscopy - document bilaterally.
Neck extended with shoulder roll - optimize operative field.
Middle thyroid vein - divide FIRST for lateral mobilization.
Superior thyroid vessels - ligate individually CLOSE TO UPPER POLE (EBSLN protection).
Inferior thyroid artery - ligate BRANCHES at capsule (NOT main trunk - parathyroid protection).
RLN - identify BEFORE dividing Berry's ligament.
Never clamp anything in the tracheoesophageal groove without visual confirmation of the RLN.
Devascularized parathyroid - autotransplant IMMEDIATELY (SCM or brachioradialis).
Intraoperative neuromonitoring (IONM) - use in all high-risk cases (re-do, malignancy, large goitre).

KEY MNEMONICS

WHIPPLE for thyroid cancer features (MALICE):

Male sex with nodule
Age <20 or >60
Lymph node involvement
Irradiation history
Consistency: hard, fixed
Extension (extrathyroidal) / E for enlarging rapidly

MEN2A = 3P: Pheochromocytoma + Parathyroid hyperplasia + (Medullary) thyroid carcinoma

BETHESDA = NBAFMS: Non-diagnostic, Benign, AUS/FLUS, Follicular, Malignant-suspicious, Malignant

RLN relations to ITA: "ABA" = Anterior 37%, Between 20%, After (posterior) 43%

COMPARISON TABLE: BAILEY & LOVE vs. SABISTON vs. ATA 2015 GUIDELINES

Topic	Bailey & Love (27e)	Sabiston (21e) / Schwartz (11e)	ATA 2015 Guideline
Extent for low-risk PTC 1-4 cm	Lobectomy acceptable	Lobectomy or total thyroidectomy	Lobectomy or total thyroidectomy (patient choice)
Prophylactic CND for T1-T2 cN0 PTC	Not routinely recommended	Not routinely recommended	Not routinely recommended
Graves surgery	Total or near-total thyroidectomy	Total or near-total preferred	Total thyroidectomy recommended
Active surveillance for PTC <1 cm	Acceptable in selected patients	Mentioned	Acceptable alternative to immediate surgery
RAI for low-risk DTC	Not routinely recommended	Not routinely recommended	Not recommended
Age cutoff for DTC staging	AJCC 8th: 55 years	AJCC 8th: 55 years	AJCC 8th: 55 years
Calcitonin universal screening	Not universally recommended	Not universally recommended	Not routinely recommended (ETA does recommend)

RECENT ADVANCES (2021-2026)

ETA 2023 Guidelines (PMID 37358008): Updated EU-TIRADS-Bethesda management algorithm; active surveillance for selected Bethesda V/VI ≤1 cm; molecular testing for indeterminate nodules
NIFTP reclassification (Nikiforov, NEJM 2016): Now well-established in clinical practice; reduces overtreatment
Selpercatinib (LOXO-292): RET-specific TKI for RET-mutant MTC and RET fusion-positive DTC - FDA approved 2020; superior efficacy and tolerability vs. first-gen TKIs
Dabrafenib + Trametinib: FDA approved 2018 for BRAF V600E-mutant ATC - first effective therapy for ATC
Pralsetinib: Second RET inhibitor for RET-mutant MTC; FDA approved 2020
Remote access thyroidectomy (RAT): Transaxillary, retroauricular, BABA (bilateral axillo-breast approach), TOETVA (transoral) - no visible neck scar; gaining acceptance in Asia
ThyroSeq v3: Next-generation sequencing panel for indeterminate thyroid nodules - 94% sensitivity, 82% specificity for malignancy
AJCC 8th edition (2017): Age cutoff 45 → 55 years; results in downstaging of many DTC patients

Sources: Schwartz's Principles of Surgery 11th Edition, Bailey & Love's Short Practice of Surgery 27th Edition, Sabiston Textbook of Surgery 21st Edition, Robbins & Kumar Basic Pathology, Robbins-Cotran Pathologic Basis of Disease, Scott-Brown's Otorhinolaryngology, ATA 2015 Management Guidelines for Thyroid Nodules and DTC, ETA 2023 Clinical Practice Guidelines for Thyroid Nodule Management (PMID: 37358008), AJCC Cancer Staging Manual 8th Edition.

---This comprehensive MS General Surgery Thyroid Long Case has been compiled from authoritative sources. Here is a summary of what is covered:

What This Document Covers

The guide spans all 18 sections of the master prompt, fully structured for university examination performance:

Clinical & Examination

Realistic university long case (38F, right STN with hoarseness)
Complete 5-minute polished case presentation script
Crile's, Lahey's, Pemberton's, Kocher's test techniques with clinical significance
All special tests with indications, technique, and interpretation

Anatomy (with textbook images)

Thyroid embryology with the Schwartz's 11e illustration (median thyroid diverticulum, pharyngeal pouches)
Cervical lymph node levels I-VII with the Schwartz's 11e illustration
Berry's ligament, Tubercle of Zuckerkandl, EBSLN Cernea classification, RLN-ITA relationships (ABA rule: 37/20/43%)
Non-recurrent laryngeal nerve - the silent killer in thyroid surgery

Classification & Staging

Complete thyroid classification flowchart
WHO goitre grading
AJCC 8th edition TNM staging (age cutoff: 45 → 55 years update)
Bethesda 6-category system with malignancy risk percentages
ACR TI-RADS scoring

Investigations

Complete algorithm from TSH → ultrasound → FNA → molecular testing
Bethesda-ATA/ETA 2023 integrated management flowchart
ThyroSeq v3, Afirma GEC molecular platforms

Management

Medical: ATD, RAI, beta blockers, L-T4 suppression targets
Surgical: Indications for lobectomy vs. total thyroidectomy (ATA 2015 vs. ETA 2023 vs. Bailey & Love comparison table)
Step-by-step total thyroidectomy operative technique
Parathyroid autotransplant technique, IONM

Complications

Neck hematoma protocol (open wound at bedside - the examiner's trap)
Hypocalcemia management flowchart
Thyroid storm management (BSTII mnemonic)

Malignancy

All 7 types with frequencies, histology, spread patterns, markers
NIFTP reclassification (2016)
BRAF V600E in PTC and ATC
MEN2 syndromes, RET mutations, codon-risk stratification
Latest TKIs: Selpercatinib, Dabrafenib+Trametinib

Viva - 25+ model Q&A chains covering anatomy, examination, investigation, operative, emergency, specimen, and histopathology vivas

Rapid Revision

Top 20 one-liners
Top 10 examiner traps
Top 10 operative pearls
Key mnemonics (MALICE, BSTII, NBAFMS, ABA)
Bailey & Love vs. Sabiston vs. ATA 2015 comparison table
Recent advances 2021-2026 (ETA 2023 PMID: 37358008, Selpercatinib, Dabrafenib+Trametinib, NIFTP, ThyroSeq v3)

Give me pdf

Reading File

Running Command

ls -la /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace/thyroid-long-case && echo "ready"

Running Command

mkdir -p /home/daytona/workspace/thyroid-long-case && echo "dir created"

Long question with real images

I'll create a comprehensive PDF with real textbook images embedded throughout. Let me build this now.

Finding Sources

Reading File

Excellent - I found the key image URLs. Let me now fetch all the real images in parallel and then build the PDF.

Loading Image

Reading File

I have 4 real textbook images. Now let me find more images (operative steps, pathology, Graves eye signs) and then build the PDF.

Reading File

I now have all the key image URLs. Let me download them all and build the comprehensive PDF.

Running Command

cd /home/daytona/workspace/thyroid-long-case && python3 -c " import urllib.request import os images = { 'embryology.png': 'https://cdn.orris.care/cdss_images/3fca66a8761f839f70f093bf833ca3d0b83af57298d8bc8fd59cac625b1241be.png', 'anatomy_vessels.png': 'https://cdn.orris.care/cdss_images/486752597f4ffad29a0e5972c68c6fabed8aa06ce8c7d4fd21ba348906b7812e.png', 'rln_ita.png': 'https://cdn.orris.care/cdss_images/e651ad1a3083f9b584690984df21e5b765208220cdbb34a63182bd06afb85441.png', 'lymph_nodes.png': 'https://cdn.orris.care/cdss_images/f75775acda71f931d7de210bb1a7bf688cec683b70282bd91861657d07aae08f.png', 'men2b_lips.png': 'https://cdn.orris.care/cdss_images/c7730f2e0b43973e32df2786f9c5427aad1de366b62e161ee3948b47e08cba11.png', 'men2b_neuromas.png': 'https://cdn.orris.care/cdss_images/665eba102b5d26d4d6bfc96cb089b46408982673117e6ae68191fc8c9bb20102.png', } for fname, url in images.items(): try: urllib.request.urlretrieve(url, fname) sz = os.path.getsize(fname) print(f'OK {fname} ({sz} bytes)') except Exception as e: print(f'FAIL {fname}: {e}') "

Give me pdf

Running Command

ls /home/daytona/workspace/thyroid-long-case/ 2>/dev/null && echo "EXISTS" || echo "MISSING"

This is a shared conversation. Sign in to Orris to start your own chat.